Physician
Pulmonology
Dr. Mark H. Gotfried, MD
|
|
Give Review
Mark Gotfried practices Pulmonology. He attended University of Illinois College of Medicine. He received awards:"Meaningful Use Stage 1 Certification". Mark H. Gotfried is a published doctor and has 53 publications published. The lastest was: 'Penetration of levofloxacin into lung tissue after oral administration to subjects undergoing lung biopsy or lobectomy.' He is registered with Medicare and accepts Medicare payments.
Publications
- Reassessment of tigecycline bone concentrations in volunteers undergoing elective orthopedic procedures.
- Efficacy of inhaled ciprofloxacin in the management of non-cystic fibrosis Bronchiectasis.
- Efficacy of Indacaterol 75 ce-Daily on Dyspnea and Health Status: Results of Two Double-Blind, Placebo-Controlled 12-Week Studies.
- Efficacy and Tolerability of Indacaterol 75 ?g Once Daily in Patients Aged ???40 Years With Chronic Obstructive Pulmonary Disease: Results From 2 Double-Blind, Placebo...
- IntraPulmonary distribution of intravenous telavancin in healthy subjects and effect of Pulmonary surfactant on in vitro activities of telavancin and other antibiotics.
- Pharmacokinetics and pharmacodynamics of intravenous levofloxacin at 750 milligrams and various doses of metronidazole in healthy adult subjects.
- Appropriate outpatient macrolide use in community-acquired Pneumonia.
- Macrolides for the treatment of chronic sinusitis, Asthma, and COPD.
- Steady-state plasma and bronchoPulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults.
- A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired Pneumonia.
- Short-course fluoroquinolones in Acute exacerbations of chronic bronchitis.
- Penetration of garenoxacin into Lung tissues and bone in subjects undergoing Lung biopsy or resection.
- Steady-state plasma and bronchoPulmonary characteristics of clarithromycin extended-release tablets in normal healthy adult subjects.
- Clarithromycin (Biaxin) extended-release tablet: a therapeutic review.
- Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose.
- Penetration of vancomycin into epithelial lining fluid in healthy volunteers.
- Insulin Lung deposition and clearance following Technosphere® insulin inhalation powder administration.
- Safety and efficacy of lomefloxacin versus cefaclor in the treatment of Acute exacerbations of chronic bronchitis.
- Evidence of remodeling in peripheral airways of patients with mild to moderate Asthma: effect of hydrofluoroalkane-flunisolide.
- Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-rel...
- Gemifloxacin use in the treatment of Acute bacterial exacerbation of chronic bronchitis.
- Identifying exposure targets for treatment of staphylococcal Pneumonia with ceftobiprole.
- Biologic lung volume reduction in advanced upper lobe Emphysema: phase 2 results.
- Telavancin penetration into human epithelial lining fluid determined by population pharmacokinetic modeling and Monte Carlo simulation.
- Role for 5-day, once-daily extended-release clarithromycin in Acute bacterial exacerbation of chronic bronchitis.
- Addition of inhaled tobramycin to ciprofloxacin for Acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
- Fluoroquinolones in the management of community-acquired Pneumonia.
- Effect of HFA-flunisolide on peripheral lung inflammation in Asthma.
- Oral gatifloxacin in outpatient community-acquired Pneumonia: results from TeqCES, a community-based, open-label, multicenter study.
- Efficacy and tolerability of gatifloxacin in community treatment of Acute exacerbations of chronic bronchitis.
- Levofloxacin penetration into epithelial lining fluid as determined by population pharmacokinetic modeling and monte carlo simulation.
- Development and implementation of the Clinical Privileges for Dietitian Nutrition Order Writing program at a long-term Acute-care hospital.
- Epidemiology of clinically diagnosed community-acquired Pneumonia in the primary care setting: results from the 1999-2000 respiratory surveillance program.
- Steady-state plasma and intraPulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects.
- Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for Acute exacerbation of chronic bronchitis.
- Long-term clarithromycin decreases prednisone requirements in elderly patients with prednisone-dependent Asthma.
- Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in Bronchiectasis.
- Comparison of bacteriologic eradication of Streptococcus Pneumoniae by clarithromycin and reports of increased antimicrobial resistance.
- Penetration of levofloxacin into Lung tissue after oral administration to subjects undergoing Lung biopsy or lobectomy.
- IntraPulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers.
- Penetration of clarithromycin into Lung tissues from patients undergoing Lung resection.
- An asymptomatic Pleural mass in a 72-year-old man.
- Diffuse epithelial pleural mesothelioma presenting as a solitary Lung mass.
- Chemoprophylaxis of Tuberculosis.
- Obstructive sleep apnea-pathogenesis and treatment.
- Behçet's Disease preceded by fever of unknown origin.
- Amino acid containing compounds in uremic serum-search for middle molecules by high performance liquid chromatography.
- Bound amino acids in uremic sera: search for peptidic middle molecules by preparative polyacrylamide gel electrophoresis and high performance liquid chromatography.
- Reduced cardiotoxicity of doxorubicin by a 6-hour infusion regimen. A prospective randomized evaluation.
- Colchicine analogues: effect on amyloidogenesis in a murine model and, in vitro, on polymorphonuclear leukocytes.
- An update on community-acquired Pneumonia in adults.
- Biologic lung volume reduction therapy for advanced homogeneous Emphysema.
Schools
University Of Illinois College Of Medicine Chicago
Michael Reese Hospital and Med Center
University Ariz
Procedures Preformed
- Bronchoscopy
Conditions Treated
- Acute Pharyngitis
- Asthma
- Atelectasis
- Breathing Disorders
- View All
Doctors Specialties
- Pulmonology
- Sleep Medicine
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
University of Arizona -
University of Illinois College of Medicine
Hospital
-
Banner Good Samaritan Medical Center -
HonorHealth John C. Lincoln Medical Center
Drug Facts
| NPI NUMBER | 1952353658 | |
| NPPES Provider LastName | GOTFRIED | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 850062611 | |
| NPPES Provider State | AZ | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 579.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1952353658 |
| Last Name Of The Provider | GOTFRIED |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
Dr. Amy A. Silverthorn, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Gregory S. Ahearn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Syed K. Shahryar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anselmo Garcia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Kari J. Williams, NP
This Doctor is OpenDoctor Recommended.
|